1993PubMedRequires access

[Treatment of migraine attacks with sumatriptan].

V. Pfaffenrath

Open publisher page 1 citations

Abstract

The serotonin agonist, sumatriptan, is a new, highly promising alternative treatment for migraine that has a vasoconstricting effect on the blood vessels dilated during an attack. In addition, sumatriptan inhibits the neurogen-mediated sterile inflammation associated with migraine. Its effects, pharmacological properties and side effects are discussed and considered in relation to its high price. The subcutaneous form of sumatriptan is indicated for use in attacks accompanied by initial violent vomiting, and the oral form for attacks in which standardised medication elicits either no response or side effects, as also to treat migraine that regularly renders the sufferer unable to work. When attacks are a frequent occurrence, migraine prophylaxis should first be initiated. The significance of cardiovascular side effects is interpreted, and hints provided on instructing the patient in the use of this drug.

About this research paper

What this paper is about

The serotonin agonist, sumatriptan, is a new, highly promising alternative treatment for migraine that has a vasoconstricting effect on the blood vessels dilated during an attack. In addition, sumatriptan inhibits the neurogen-mediated sterile inflammation associated with migraine. Its effects, pharmacological properties and side effects are discussed and considered in relation to its high price. The subcutaneous form of sumatriptan is indicated for use in attacks accompanied by initial violent vomiting, and the oral form for attacks in which standardised medication elicits either no response or side effects, as also to treat migraine that regularly renders the sufferer unable to work. When attacks are a frequent occurrence, migraine prophylaxis should first be initiated. The significance of cardiovascular side effects is interpreted, and hints provided on instructing the patient in the use of this drug.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The serotonin agonist, sumatriptan, is a new, highly promising alternative treatment for migraine that has a vasoconstricting effect on the blood vessels dilated during an attack. In addition, sumatriptan inhibits the neurogen-mediated sterile inflammation associated with migraine. Its effects, pharmacological properties and side effects are discussed and considered in relation to its high price. The subcutaneous form of sumatriptan is indicated for use in attacks accompanied by initial violent vomiting, and the oral form for attacks in which standardised medication elicits either no response or side effects, as also to treat migraine that regularly renders the sufferer unable to work. When attacks are a frequent occurrence, migraine prophylaxis should first be initiated. The significance of cardiovascular side effects is interpreted, and hints provided on instructing the patient in the use of this drug.

Key concepts: Sumatriptan, Migraine, Medicine, Serotonin Agonist, Vomiting, Agonist, Anesthesia, Nausea

Related papers

Back to paper searchBrowse research topicsOriginal source
[Treatment of migraine attacks with sumatriptan]. — Research Paper | ScholarLens